The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Current Understanding of the Role of Complement in IgA Nephropathy
Open accessAbstract
Complement activation has a role in the pathogenesis of IgA nephropathy, an autoimmune disease mediated by pathogenic immune complexes consisting of galactose-deficient IgA1 bound by antiglycan antibodies. Of three complement-activation pathways, the alternative and lectin pathways are involved in IgA nephropathy. IgA1 can activate both pathways in vitro, and pathway components are present in the mesangial immunodeposits, including properdin and factor H in the alternative pathway and mannan-binding lectin, mannan-binding lectin-associated serine proteases 1 and 2, and C4d in the lectin pathway. Genome-wide association studies identified deletion of complement factor H-related genes 1 and 3 as protective against the disease. Because the corresponding gene products compete with factor H in the regulation of the alternative pathway, it has been hypothesized that the absence of these genes could lead to more potent inhibition of complement by factor H. Complement activation can take place directly on IgA1-containing immune complexes in circulation and/or after their deposition in the mesangium. Notably, complement factors and their fragments may serve as biomarkers of IgA nephropathy in serum, urine, or renal tissue. A better understanding of the role of complement in IgA nephropathy may provide potential targets and rationale for development of complement-targeting therapy of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran, D. C., Coppo, R., Cook, H. T., Feehally, J., Roberts, I. S. D., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., et al. (2009) · Kidney International · doi:10.1038/ki.2009.243 · Cited by 1,235
Self-citationWyatt, R. J., & Julian, B. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1206793 · Cited by 1,222
Self-citationA Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts, I. S. D., Cook, H. T., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., Berthoux, F., Bonsib, S., Bruijn, J. A., et al. (2009) · Kidney International · doi:10.1038/ki.2009.168 · Cited by 1,038
Self-citationThe Pathophysiology of IgA Nephropathy
Suzuki, H., Kiryluk, K., Novak, J., Moldoveanu, Z., Herr, A. B., Renfrow, M. B., Wyatt, R. J., Scolari, F., Mestecky, J., Gharavi, A. G., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050464 · Cited by 910
Self-citation[Intercapillary deposits of IgA-IgG].
Berger, J., & Hinglais, N. (1968) · PubMed · Cited by 800
Fremeaux-Bacchi, V., Fakhouri, F., Garnier, A., Bienaimé, F., Dragon-Durey, M.-A., Ngo, S., Moulin, B., Servais, A., Provot, F., Rostaing, L., et al. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04760512 · Cited by 714
Self-citationC3 glomerulopathy: consensus report
Pickering, M. C., D'Agati, V. D., Nester, C. M., Smith, R. J., Haas, M., Appel, G. B., Alpers, C. E., Bajema, I. M., Bedrosian, C., Braun, M., et al. (2013) · Kidney International · doi:10.1038/ki.2013.377 · Cited by 653
Kiryluk, K., Li, Y., Scolari, F., Sanna-Cherchi, S., Choi, M., Verbitsky, M., Fasel, D., Lata, S., Prakash, S., Shapiro, S., et al. (2014) · Nature Genetics · doi:10.1038/ng.3118 · Cited by 628
Self-citationGenome-wide association study identifies susceptibility loci for IgA nephropathy
Gharavi, A. G., Kiryluk, K., Choi, M., Li, Y., Hou, P., Xie, J., Sanna-Cherchi, S., Men, C. J., Julian, B. A., Wyatt, R. J., et al. (2011) · Nature Genetics · doi:10.1038/ng.787 · Cited by 624
Self-citationSahu, A., & Lambris, J. D. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800103.x · Cited by 525
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Suzuki, H., Fan, R., Zhang, Z., Brown, R., Hall, S., Julian, B. A., Chatham, W. W., Suzuki, Y., Wyatt, R. J., Moldoveanu, Z., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38468 · Cited by 450
Self-citationRoos, A., Rastaldi, M. P., Calvaresi, N., Oortwijn, B. D., Schlagwein, N., van Gijlswijk-Janssen, D. J., Stahl, G. L., Matsushita, M., Fujita, T., van Kooten, C., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090923 · Cited by 450
Human IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway
Roos, A., Bouwman, L. H., van Gijlswijk-Janssen, D. J., Faber-Krol, M. C., Stahl, G. L., & Daha, M. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2861 · Cited by 431
Kiryluk, K., Li, Y., Sanna-Cherchi, S., Rohanizadegan, M., Suzuki, H., Eitner, F., Snyder, H. J., Choi, M., Hou, P., Scolari, F., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002765 · Cited by 383
Self-citationMoore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P. N., Herbert, A. P., Schmidt, C. Q., Staniforth, S. J., Holmes, L. V., Ward, R., et al. (2010) · Blood · doi:10.1182/blood-2009-05-221549 · Cited by 357
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
Józsi, M., Licht, C., Strobel, S., Zipfel, S. L. H., Richter, H., Heinen, S., Zipfel, P. F., & Skerka, C. (2008) · Blood · doi:10.1182/blood-2007-09-109876 · Cited by 354
Conley, M. E., Cooper, M. D., & Michael, A. F. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109998 · Cited by 331
Richards, A., Buddles, M. R., Donne, R. L., Kaplan, B. S., Kirk, E., Venning, M. C., Tielemans, C. L., Goodship, J. A., & Goodship, T. H. J. (2001) · The American Journal of Human Genetics · doi:10.1086/318203 · Cited by 310
Pérez-Caballero, D., González-Rubio, C., Gallardo, M. E., Vera, M., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2001) · The American Journal of Human Genetics · doi:10.1086/318201 · Cited by 293
Servais, A., Frémeaux-Bacchi, V., Lequintrec, M., Salomon, R., Blouin, J., Knebelmann, B., Grünfeld, J.-P., Lesavre, P., Noël, L.-H., & Fakhouri, F. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045328 · Cited by 291
Dimerization of complement factor H-related proteins modulates complement activation in vivo
Goicoechea de Jorge, E., Caesar, J. J. E., Malik, T. H., Patel, M., Colledge, M., Johnson, S., Hakobyan, S., Morgan, B. P., Harris, C. L., Pickering, M. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219260110 · Cited by 289
Heinen, S., Hartmann, A., Lauer, N., Wiehl, U., Dahse, H.-M., Schirmer, S., Gropp, K., Enghardt, T., Wallich, R., Hälbich, S., et al. (2009) · Blood · doi:10.1182/blood-2009-02-205641 · Cited by 272
Complement factor H related proteins (CFHRs)
Skerka, C., Chen, Q., Fremeaux-Bacchi, V., & Roumenina, L. T. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.06.001 · Cited by 264
Self-citationLaunay, P., Grossetête, B., Arcos-Fajardo, M., Gaudin, E., Torres, S. P., Beaudoin, L., Patey-Mariaud de Serre, N., Lehuen, A., & Monteiro, R. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1999 · Cited by 254
Hageman, G. S., Hancox, L. S., Taiber, A. J., Gehrs, K. M., Anderson, D. H., Johnson, L. V., Radeke, M. J., Kavanagh, D., Richards, A., Atkinson, J., et al. (2006) · Annals of Medicine · doi:10.1080/07853890601097030 · Cited by 246
Józsi, M., Strobel, S., Dahse, H.-M., Liu, W.-S., Hoyer, P. F., Oppermann, M., Skerka, C., & Zipfel, P. F. (2007) · Blood · doi:10.1182/blood-2007-02-071472 · Cited by 233
Zhao, J., Wu, H., Khosravi, M., Cui, H., Qian, X., Kelly, J. A., Kaufman, K. M., Langefeld, C. D., Williams, A. H., Comeau, M. E., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002079 · Cited by 231
Properdin: Emerging Roles of a Pattern-Recognition Molecule
Kemper, C., Atkinson, J. P., & Hourcade, D. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101250 · Cited by 228
The genetics and immunobiology of IgA nephropathy
Kiryluk, K., & Novak, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74475 · Cited by 224
Self-citationAssociation of C4d Deposition with Clinical Outcomes in IgA Nephropathy
Espinosa, M., Ortega, R., Sánchez, M., Segarra, A., Salcedo, M. T., González, F., Camacho, R., Valdivia, M. A., Cabrera, R., López, K., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09710913 · Cited by 218
Abarrategui-Garrido, C., Martínez-Barricarte, R., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2009) · Blood · doi:10.1182/blood-2009-05-223834 · Cited by 206
Fritsche, L. G., Lauer, N., Hartmann, A., Stippa, S., Keilhauer, C. N., Oppermann, M., Pandey, M. K., Köhl, J., Zipfel, P. F., Weber, B. H. F., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq399 · Cited by 203
Cellular Response to Injury in Membranous Nephropathy
Nangaku, M., Shankland, S. J., & Couser, W. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121098 · Cited by 203
C3 glomerulopathy–associated CFHR1 mutation alters FHR oligomerization and complement regulation
Tortajada, A., Yébenes, H., Abarrategui-Garrido, C., Anter, J., García-Fernández, J. M., Martínez-Barricarte, R., Alba-Domínguez, M., Malik, T. H., Bedoya, R., Pérez, R. C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68280 · Cited by 197
Activation of the alternative pathway of complement by human serum IgA
Hiemstra, P. S., Gorter, A., Stuurman, M. E., Van Es, L. A., & Daha, M. R. (1987) · European Journal of Immunology · doi:10.1002/eji.1830170304 · Cited by 193
Endo, M. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.8.1984 · Cited by 182
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
Berthelot, L., Papista, C., Maciel, T. T., Biarnes-Pelicot, M., Tissandie, E., Wang, P. H. M., Tamouza, H., Jamin, A., Bex-Coudrat, J., Gestin, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112005 · Cited by 182
Natural History of Primary IgA Nephropathy
Berthoux, F. C., Mohey, H., & Afiani, A. (2008) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.10.001 · Cited by 177
Complement activation by (auto-) antibodies
Daha, N. A., Banda, N. K., Roos, A., Beurskens, F. J. M., Bakker, J. M., Daha, M. R., & Trouw, L. A. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.04.024 · Cited by 171
Hellwage, J., Jokiranta, T. S., Koistinen, V., Vaarala, O., Meri, S., & Zipfel, P. F. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01554-9 · Cited by 168
Kim, S. J., Koo, H. M., Lim, B. J., Oh, H. J., Yoo, D. E., Shin, D. H., Lee, M. J., Doh, F. M., Park, J. T., Yoo, T.-H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040495 · Cited by 164
Zhu, L., Zhai, Y.-L., Wang, F.-M., Hou, P., Lv, J.-C., Xu, D.-M., Shi, S.-F., Liu, L.-J., Yu, F., Zhao, M.-H., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010096 · Cited by 164
Self-citationComplement membrane attack (MAC) in idiopathic IgA-glomerulonephritis
Rauterberg, E. W., Lieberknecht, H., Wingen, A., & Ritz, E. (1987) · Kidney International · doi:10.1038/ki.1987.72 · Cited by 162
Alternative complement pathway assessment in patients with atypical HUS
Roumenina, L. T., Loirat, C., Dragon‐Durey, M., Halbwachs‐Mecarelli, L., Sautès‐Fridman, C., & Frémeaux‐Bacchi, V. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.12.020 · Cited by 157
A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy
Karoui, K. E., Hill, G. S., Karras, A., Jacquot, C., Moulonguet, L., KOURILSKY, O., Frémeaux‐Bacchi, V., Delahousse, M., Huyen, J. D. V., Loupy, A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111130 · Cited by 153
Russell, M. W., Reinholdt, J., & Kilian, M. (1989) · European Journal of Immunology · doi:10.1002/eji.1830191210 · Cited by 152
Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32
Holmes, L. V., Strain, L., Staniforth, S. J., Moore, I., Marchbank, K. J., Kavanagh, D., Goodship, J. A., Cordell, H. J., & Goodship, T. H. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060352 · Cited by 138
Eculizumab treatment for rescue of renal function in IgA nephropathy
Rosenblad, T., Rebetz, J., Johansson, M., Békássy, Z. D., Sartz, L., & Karpman, D. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2863-y · Cited by 127
Activated complement C3: A potentially novel predictor of progressive IgA nephropathy
Zwirner, J., Burg, M., Schulze, M. B., Brunkhorst, R. R., Götze, O., Km, K., & Floege, J. (1997) · Kidney International · doi:10.1038/ki.1997.171 · Cited by 120
Russell, M. W., & Mansa, B. (1989) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1989.tb01199.x · Cited by 104
Vuong, M. T., Hahn‐Zoric, M., Lundberg, S. G. G., Gunnarsson, I., van Kooten, C., Wramner, L., Seddighzadeh, M., Fernström, A., Hanson, L. Å., Lieu, T. D., et al. (2010) · Kidney International · doi:10.1038/ki.2010.314 · Cited by 97
Suzuki, Y., Matsuzaki, K., Suzuki, H., Okazaki, K., Yanagawa, H., Ieiri, N., Sato, M., Sato, T., Taguma, Y., Matsuoka, J., et al. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0921-6 · Cited by 91
Ansari, M., McKeigue, P., Skerka, C., Hayward, C., Rudan, I., Vitart, V., Polašek, O., Armbrecht, A.-M., Yates, J. R. W., Vatavuk, Z., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt336 · Cited by 91
Recent insights into C3 glomerulopathy
Barbour, T., Pickering, M. C., & Cook, H. T. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs430 · Cited by 83
Complement activation in IgA nephropathy
Wyatt, R. J., Kanayama, Y., Julian, B. A., et al. (1987) · Kidney International · doi:10.1038/ki.1987.101 · Cited by 82
Self-citationVaris, J., Rantala, I. S., Pasternack, A. I., et al. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.7.607 · Cited by 82
Timmann, C., Leippe, M., & Horstmann, R. D. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1265 · Cited by 81
Braun, M., Reins, R. Y., Li, T.-B., Hollmann, T. J., Dutta, R., Rick, W. A., Teng, B.-B., & Ke, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4190 · Cited by 80
van den Dobbelsteen, M. E. A., Verhasselt, V., Kaashoek, J. G. J., Timmerman, J. J., Schroeijers, W. E. M., Verweij, C. L., van der Woude, F. J., van Es, L. A., & Daha, M. R. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06033.x · Cited by 76
Wyatt, R. J., Julian, B. A., & Galla, J. H. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110293051827 · Cited by 71
Self-citationZhang, J., Li, Y., Shan, K., Wang, L., Qiu, W., Lu, Y., Zhao, D., Zhu, G., He, F., & Wang, Y. (2013) · The FASEB Journal · doi:10.1096/fj.13-242693 · Cited by 63
Schmitt, R., Ståhl, A.-L., Olin, A. I., Kristoffersson, A., Rebetz, J., Novák, J., Lindahl, G., & Karpman, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302249 · Cited by 63
New insights into the pathogenesis of IgA nephropathy
Floege, J., Moura, I. C., & Daha, M. R. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-013-0411-7 · Cited by 62
Activation of Complement in IgA Nephropathy
Wyatt, R. J., & Julian, B. A. (1988) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(88)80042-8 · Cited by 58
Self-citationExpression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney
Abe, K., Miyazaki, M., Koji, T., Furusu, A., Ozono, Y., Harada, T., Sakai, H., Nakane, P. K., & Kohno, S. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00961.x · Cited by 48
Qiu, W., Zhou, J., Zhu, G., Zhao, D., He, F., Zhang, J., Lu, Y., Yu, T., Liu, L., & Wang, Y. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.153 · Cited by 45
Maeng, Y., Kim, M., Park, J.-B., et al. (2013) · PubMed · Cited by 40
Copy number variation in the complement factor H-related genes and age-related macular degeneration.
Schmid‐Kubista, K. E., Tosakulwong, N., Wu, Y., Ryu, E., Roeder, J. L., Hecker, L. A., Baratz, K. H., Brown, W. L., & Edwards, A. O. (2011) · PubMed Central · Cited by 40
Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy
Miyamoto, H., Yoshioka, K., Takemura, T., Akano, N., & Maki, S. (1988) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00844284 · Cited by 39
Significance of Glomerular Deposition of C3c and C3d in IgA Nephropathy
Nakagawa, H., Suzuki, S., Haneda, M., Gejyo, F., & Kikkawa, R. (2000) · American Journal of Nephrology · doi:10.1159/000013568 · Cited by 33
Cosio, F. G., Shibata, T., Rovin, B. H., & Birmingham, D. J. (1994) · Kidney International · doi:10.1038/ki.1994.358 · Cited by 33
C4B Deficiency in Two Siblings With IgA Nephropathy
Wyatt, R. J., Schneider, P. D., Alpers, C. E., Hudson, E. C., & Julian, B. A. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80594-4 · Cited by 9
Self-citation
Cited by
Rodrigues, J. C., Haas, M., & Reich, H. N. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07420716 · Cited by 555
Lai, K. N., Tang, S. C. W., Schena, F. P., Novak, J., Tomino, Y., Fogo, A. B., & Glassock, R. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.1 · Cited by 508
Self-citationLv, J., Wong, M. G., Hladunewich, M. A., Jha, V., Hooi, L. S., Monaghan, H., Zhao, M., Barbour, S., Jardine, M. J., Reich, H. N., et al. (2022) · JAMA · doi:10.1001/jama.2022.5368 · Cited by 354
Floege, J., Barbour, S. J., Cattran, D. C., Hogan, J. J., Nachman, P. H., Tang, S. C. W., Wetzels, J. F. M., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.10.018 · Cited by 263
“Glomerular injury in IgAN is associated with activation of the complement system.(67,68) This is supported by genetic mapping and clinical reports of eculizumab rescuing crescentic IgAN.”
ResultThe pathogenesis of IgA nephropathy and implications for treatment
Cheung, C. K., Alexander, S., Reich, H. N., Selvaskandan, H., Zhang, H., & Barratt, J. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00885-3 · Cited by 222
Metadata
- Authors
- Maillard, N., Wyatt, R. J., Julian, B. A., Kiryluk, K., Gharavi, A., Fremeaux-Bacchi, V., & Novak, J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-07
- Volume
- 26
- Issue
- 7
- Pages
- 1503-1512
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2017568050
- Cited by
- 338
- References
- 74
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.